Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Bayer claims new proteasome inhibitors for asthma and cancer

Oct. 11, 2004

AVE-5883 pharmacokinetics similar in healthy and asthmatic subjects

Oct. 8, 2004

New beta2-adrenoceptor agonists covered by GSK patent

Oct. 8, 2004

New glucocorticoid receptor agonists emerge from GSK R&D

Oct. 8, 2004

Two novel series of chemokine CCR2 antagonists identified at BMS

Oct. 6, 2004

U.K. approval for QVAR in Easi-Breathe inhaler

Oct. 5, 2004

Abbott presents new PDE4 and TNF-alpha production inhibitors

Oct. 1, 2004

Glenmark and Forest collaborate on GRC-3886

Sep. 29, 2004

Novel PDE4 inhibitors prepared and tested at Kyowa Hakko

Sep. 27, 2004

Antiinflammatory and therapeutic effects of ciclesonide in asthma

Sep. 23, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.